Intriguingly, peripheral insulin resistance and type 2 diabetes have been demonstrated to decrease Aβ clearance, reduce gray matter volume, increase tau deposition, and accelerate cognitive decline in individuals with AD (30). This evidence concerns the gene MAPT and Alzheimer disease.